News Accuray Incorporated

Equities

ARAY

US0043971052

Real-time Estimate Cboe BZX Other stock markets 10:17:22 2024-04-16 am EDT			5-day change	1st Jan Change
2.265 ^USD	-1.95%		-6.43%	-20.32%

Mar. 26	Accuray Incorporated Announces New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can Be Effectively Treated in 5 Days Using the Accuray CyberKnife System	CI
Feb. 13	Roth MKM Starts Accuray With Buy Rating, $9 Price Target	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System	Mar. 26	PR
Accuray Incorporated Announces New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can Be Effectively Treated in 5 Days Using the Accuray CyberKnife System	Mar. 26	CI
Accuray Incorporated to Speak at 36th Annual Roth Conference	Mar. 04	PR
Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference	Feb. 27	PR
Roth MKM Starts Accuray With Buy Rating, $9 Price Target	Feb. 13	MT
Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System	Feb. 13	PR
Quebec Cancer Center Is First in Canada to Treat Cancer Patients Using the Accuray Radixact System	Feb. 13	CI
The Royal Marsden set to be the first center in the world to implement online adaptive radiation therapy utilizing ARTemis from RaySearch	Feb. 08	AQ
Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference	Feb. 05	PR
Accuray: Fiscal Q2 Earnings Snapshot	Jan. 31	AQ
Transcript : Accuray Incorporated, Q2 2024 Earnings Call, Jan 31, 2024	Jan. 31
Earnings Flash (ARAY) ACCURAY INCORPORATED Posts Q2 Revenue $107.2M, vs. Street Est of $106.7M	Jan. 31	MT
Accuray Incorporated Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Jan. 31	CI
Accuray Incorporated Reaffirms Revenue Guidance for the Third Quarter and Full Fiscal Year 2024	Jan. 31	CI
Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions	Jan. 25	PR
Accuray Incorporated Announces the Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray Cyberknife System	Jan. 25	CI
Accuray to Report Second Quarter Fiscal 2024 Financial Results on January 31, 2024	Jan. 16	PR
C-RAD announces order from Accuray	Jan. 15	AQ
Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® System	Dec. 05	PR
Accuray Insider Sold Shares Worth $161,624, According to a Recent SEC Filing	Dec. 05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Accuray Incorporated

Equities

ARAY

US0043971052

Summary

Filters